新規超音波ネブライザーにおける気管支拡張剤の安定性
書誌事項
- タイトル別名
-
- STAIBILITY OF BRONCHODILATERS USING NEW ULTRASONIC NEBULIZER
この論文をさがす
抄録
Ultrasonic nebulization is widely performed for inhaant therapy. But there still remain some problems in the stability of the drugs in inhalant solutions during ultrasonic nebulization. We have reported that the remaining ratios of some bronchodilaters were below 90% after nebulization using the conventional ultrasonic nebulizer.<BR>A new ultrasonic nebulizer has been developed by OMRON. We investigated the effect of the new ultrasonic nebulizer on the stability of bronchodilaters for inhalant therapy. Stability tests were performed on bronchodilaters in terms of visible change, pH and degradation rate of the drug using HPLC after ultrasonic nebulization.<BR>The results may be summarized as follows. The ratios of all bronchodilaters remained at more than 95% after 8 minutes of ultrasonic nebulization using the new ultrasonic nebulizer.<BR>Therefore, bronchodilaters are highly stableusing new ultrasonic nebulizer and should be effective. We concluded that the new ultrasonic nebulizing method can be applied in the inhalant therapy of many inhalant preparations.
収録刊行物
-
- 耳鼻咽喉科展望
-
耳鼻咽喉科展望 38 (Supplement2), 114-118, 1995
耳鼻咽喉科展望会
- Tweet
詳細情報 詳細情報について
-
- CRID
- 1390282679930238848
-
- NII論文ID
- 130003974812
-
- ISSN
- 18836429
- 03869687
-
- 本文言語コード
- ja
-
- データソース種別
-
- JaLC
- CiNii Articles
-
- 抄録ライセンスフラグ
- 使用不可